ロード中...
Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis
Despite progress in pharmacotherapy, there still are urgent needs in the development of new methods of drug therapy of rheumatoid arthritis (RA). New prospects for drug therapy are currently associated with sarilumab (SAR), recently registered in the Russian Federation for the treatment of moderate...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Remedium Group LLC
2019-12-01
|
| シリーズ: | Медицинский совет |
| 主題: | |
| オンライン･アクセス: | https://www.med-sovet.pro/jour/article/view/4970 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|